What's in Ansun Biopharma, Inc.'s pipeline?

Ansun Biopharma, Inc. has 7 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 4 in Phase 2, 0 in Phase 1.

Which companies overlap with Ansun Biopharma, Inc.'s portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ansun-biopharma-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Ansun Biopharma, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ansun Biopharma, Inc. pipeline: 0 marketed, 0 filed, 3 Phase 3, 4 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 4 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
DAS181	DAS181	phase 3	Recombinant fusion protein; viral entry inhibitor	DPP4 (dipeptidyl peptidase 4) receptor	Infectious Disease; Virology
DAS181 COVID-19	DAS181 COVID-19	phase 3	ACE2 receptor decoy / recombinant fusion protein	SARS-CoV-2 spike protein (via ACE2 binding domain)	Infectious Disease / Virology
DAS181 OL	DAS181 OL	phase 3	Recombinant fusion protein / Antiviral	ACE2 receptor domain (viral spike protein binding)	Infectious Disease / Virology

Therapeutic area mix

Infectious Disease / Virology · 2
Infectious Disease; Virology · 1
Respiratory · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Ansun Biopharma, Inc.:

Cite this brief

Drug Landscape (2026). Ansun Biopharma, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ansun-biopharma-inc. Accessed 2026-05-16.